載入中
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
一般交易時段
US$45.105
+US$0.685 · +1.54%
盤中時間採用ET。市場資料可能有所延遲。
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
日內區間
目前US$45.105
52週區間
目前US$45.105
盤中時間採用ET。市場資料可能有所延遲。
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
日內區間
目前US$45.105
52週區間
目前US$45.105
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 13.74億 USD | 13.07億 USD | 12.45億 USD | 10.45億 USD | 10.11億 USD |
| 銷貨成本 | 6.49億 USD | 5.74億 USD | 5.68億 USD | 4.74億 USD | 4.43億 USD |
| 毛利 | 7.25億 USD | 7.33億 USD | 6.76億 USD | 5.71億 USD | 5.68億 USD |
| 研究與開發 | 5588.4萬 USD | 5442.6萬 USD | 5260.2萬 USD | 4715.2萬 USD | 4356.5萬 USD |
| 銷售、一般及管理費用 | 5.28億 USD | 4.78億 USD | 5.03億 USD | 4.54億 USD | 4.15億 USD |
| 營業費用 | 5.84億 USD | 5.33億 USD | 5.56億 USD | 5.01億 USD | 4.58億 USD |
| 利息支出 | 3108.7萬 USD | 3729.7萬 USD | 3977.5萬 USD | 2890.5萬 USD | 3548.5萬 USD |
| 折舊和攤銷 | 7428.1萬 USD | 5130.5萬 USD | 5140萬 USD | 6951.9萬 USD | 7074.3萬 USD |
| 營業利益 | 1.41億 USD | 2億 USD | 1.21億 USD | 7005.4萬 USD | 1.1億 USD |
| 淨利 | 4705.5萬 USD | 1.32億 USD | 6445.9萬 USD | −8058.2萬 USD | 6254.2萬 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$37.50
下跌空間 16.86%年度分割調整後的每股現金分配。
US$0.80
2024年（完整年度）0.0% 自從 2020
US$0.80
2,020
US$0.80
2,021
US$0.80
2,022
US$0.80
2,023
US$0.80
2,024
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2025年9月15日 | US$0.20Quarterly | 2025年9月15日 | 2025年10月3日 |
股息 | 2025年6月13日 | US$0.20Quarterly | 2025年6月13日 | 2025年7月3日 |
股息 | 2025年3月14日 | US$0.20Quarterly | 2025年3月14日 | 2025年4月4日 |
股息 | 2024年12月20日 | US$0.20Quarterly | 2024年12月20日 | 2025年1月3日 |
股息 | 2024年9月16日 | US$0.20Quarterly | 2024年9月16日 | 2024年10月4日 |
股息 | 2024年6月14日 | US$0.20Quarterly | 2024年6月14日 | 2024年7月5日 |
除息 2025年9月15日
US$0.20
Quarterly
2025年9月15日登記 · 支付日 2025年10月3日
除息 2025年6月13日
US$0.20
Quarterly
2025年6月13日登記 · 支付日 2025年7月3日
除息 2025年3月14日
US$0.20
Quarterly
2025年3月14日登記 · 支付日 2025年4月4日
除息 2024年12月20日
US$0.20
Quarterly
2024年12月20日登記 · 支付日 2025年1月3日
除息 2024年9月16日
US$0.20
Quarterly
2024年9月16日登記 · 支付日 2024年10月4日
除息 2024年6月14日
US$0.20
Quarterly
2024年6月14日登記 · 支付日 2024年7月5日
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI4776.33萬0.00%2.3兆 USD0.03%US$381.49-0.12%
iShares Russell 2000 ETFIWM3581萬0.05%787.4億 USD0.19%US$278.09-0.31%
Vanguard Morningstar Small-Cap ETFVB3449.39萬0.02%1853億 USD0.03%US$288.54-0.33%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV2506.91萬0.09%268.09億 USD0.33%US$38.115+0.43%
Vanguard Morningstar Small-Cap Value ETFVBR2193.22萬0.03%682億 USD0.05%US$234.96+0.23%
Vanguard Extended Market ETFVXF1739.38萬0.02%954億 USD0.05%US$233.76-0.53%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1219.83萬0.08%158.4億 USD0.03%US$53.5401+0.17%
Dimensional - US Targeted Value ETFDFAT1048.14萬0.03%301.22億 USD0.33%US$67.665+0.59%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBU.S. Small Cap Value Portfolio ETF Class SharesDFSVVanguard Morningstar Small-Cap Value ETFVBRVanguard Extended Market ETFVXFState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMDimensional - US Targeted Value ETFDFATAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
